The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent β-thalassemia in Taiwan

Deferasirox is a novel once-daily, oral iron chelator. The aim of this study was to evaluate the long-term efficacy and tolerability of deferasirox in Taiwanese patients with transfusion-dependent β-thalassemia who have been treated with deferasirox for 7 years. Taiwanese patients aged ≥2 years with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hsiu-Hao, Lu, Meng-Yao, Peng, Steven Shinn-Forng, Yang, Yung-Li, Lin, Dong-Tsamn, Jou, Shiann-Tarng, Lin, Kai-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604499/
https://www.ncbi.nlm.nih.gov/pubmed/26404899
http://dx.doi.org/10.1007/s00277-015-2476-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604499/
https://www.ncbi.nlm.nih.gov/pubmed/26404899
http://dx.doi.org/10.1007/s00277-015-2476-y

Ejemplares similares